DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/rbp5bl/investigation) has announced the addition of the "Investigation Report on China's Glipizide Market, 2010-2019" report to their offering. As one of the earliest oral antidiabetic drugs, sulfonylurea is common to patients with insulin hyposecretion. By stimulating insulin secretion, sulfonylurea is able to reduce blood glucose. According to the length of action, sulfonylurea can be categorized into sh
| < Prev | Next > |
|---|
